• Placement to raise up to $12 million through issue of 66.7 million new shares at $0.18 per share
• Share Purchase Plan to raise up to $8 million for eligible shareholders at $0.18 per share or 2.5% discount to VWAP
• Attaching Options and Piggyback Options to be issued to Placement and SPP participants

Imugene Ltd has announced a prospectus for a capital raising comprising a $12 million placement and up to $8 million share purchase plan. Under the placement, the company will issue up to 66.7 million new shares at $0.18 per share to institutional and sophisticated investors. The share purchase plan will allow eligible shareholders to acquire up to $30,000 worth of new shares at the lower of $0.18 per share or a 2.5% discount to the 5-day VWAP. Participants in both the placement and share purchase plan will receive one free attaching option for every new share, exercisable at $0.18 per option by 30 April 2027. Additionally, one free piggyback option will be issued for every attaching option exercised, with an exercise price of $0.30 and expiry of 30 April 2029. The share purchase plan and new options are subject to shareholder approval at an extraordinary general meeting expected in April 2026.